A knowledge graph of clinical trials ([Formula: see text])
- PMID: 35304504
- PMCID: PMC8933553
- DOI: 10.1038/s41598-022-08454-z
A knowledge graph of clinical trials ([Formula: see text])
Abstract
Effective and successful clinical trials are essential in developing new drugs and advancing new treatments. However, clinical trials are very expensive and easy to fail. The high cost and low success rate of clinical trials motivate research on inferring knowledge from existing clinical trials in innovative ways for designing future clinical trials. In this manuscript, we present our efforts on constructing the first publicly available Clinical Trials Knowledge Graph, denoted as [Formula: see text]. [Formula: see text] includes nodes representing medical entities in clinical trials (e.g., studies, drugs and conditions), and edges representing the relations among these entities (e.g., drugs used in studies). Our embedding analysis demonstrates the potential utilities of [Formula: see text] in various applications such as drug repurposing and similarity search, among others.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Friedman LM, Furberg CD, DeMets DL, Reboussin DM, Granger CB. Fundamentals of Clinical Trials. Cham: Springer; 2015.
-
- Sertkaya A, Wong H-H, Jessup A, Beleche T. Key cost drivers of pharmaceutical clinical trials in the united states. Clin. Trials. 2016;13:117–126. - PubMed
-
- Tasneem A, et al. The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty. PLoS ONE. 2012;7:e33677 e33677. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
